Helix BioPharma Corp. (HBPCF)
OTCMKTS · Delayed Price · Currency is USD
1.734
+1.134 (189.00%)
At close: Oct 22, 2025
Helix BioPharma Market Cap
Helix BioPharma has a market cap or net worth of $102.17 million as of February 6, 2026. Its market cap has increased by 182.14% in one year.
Market Cap
102.17M
Enterprise Value
102.06M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.73
Market Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 6.90M to 102.17M, an increase of 1,381.54%. That is a compound annual growth rate of 9.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 102.17M | -22.61% |
| Dec 31, 2025 | 132.02M | 335.39% |
| Dec 31, 2024 | 30.32M | -11.99% |
| Dec 29, 2023 | 34.45M | 8.43% |
| Dec 30, 2022 | 31.77M | -5.92% |
| Dec 31, 2021 | 33.77M | -36.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 311.73M |
| Silence Therapeutics | 213.97M |
| Vaxart | 149.51M |
| BioStem Technologies | 100.03M |
| Nuo Therapeutics | 78.22M |
| HST Global | 74.26M |
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |